Vitalhub Corp. (TSE:VHI) Stock Has Consensus Price Target of C$13.00

Shares of Vitalhub Corp. (TSE:VHI) have been assigned a consensus recommendation of “Buy” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is C$13.00.

Separately, Canaccord Genuity Group set a C$15.00 price target on Vitalhub and gave the company a “buy” rating in a research note on Friday, August 28th.

Vitalhub Trading Down 0.1%

Shares of TSE:VHI opened at C$7.49 on Friday. The company has a 50 day moving average of C$7.66 and a 200-day moving average of C$7.43. The firm has a market cap of C$474.41 million, a P/E ratio of 62.42, a P/E/G ratio of 1.18 and a beta of 1.40. Vitalhub has a twelve month low of C$6.46 and a twelve month high of C$11.80.

Vitalhub (TSE:VHI) last posted its quarterly earnings data on Thursday, August 6th. The company reported C$0.03 earnings per share (EPS) for the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. The business had revenue of C$31.74 million during the quarter. Equities research analysts forecast that Vitalhub will post 0.2296467 EPS for the current year.

About Vitalhub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.